<?xml version="1.0" encoding="utf-8" ?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN"
                  "JATS-publishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.2" article-type="other">
<front>
<journal-meta>
<journal-id></journal-id>
<journal-title-group>
<journal-title>Journal of Open Source Software</journal-title>
<abbrev-journal-title>JOSS</abbrev-journal-title>
</journal-title-group>
<issn publication-format="electronic">2475-9066</issn>
<publisher>
<publisher-name>Open Journals</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1269</article-id>
<article-id pub-id-type="doi">10.21105/joss.01269</article-id>
<title-group>
<article-title>riskclustr: Functions to Study Etiologic
Heterogeneity</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">0000-0002-1402-4498</contrib-id>
<string-name>Emily C. Zabor</string-name>
<xref ref-type="aff" rid="aff-1"/>
</contrib>
<aff id="aff-1">
<institution-wrap>
<institution>Memorial Sloan Kettering Cancer Center</institution>
</institution-wrap>
</aff>
</contrib-group>
<pub-date date-type="pub" publication-format="electronic" iso-8601-date="2019-02-19">
<day>19</day>
<month>2</month>
<year>2019</year>
</pub-date>
<volume>4</volume>
<issue>35</issue>
<fpage>1269</fpage>
<permissions>
<copyright-statement>Authors of papers retain copyright and release the
work under a Creative Commons Attribution 4.0 International License (CC
BY 4.0)</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>The article authors</copyright-holder>
<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/">
<license-p>Authors of papers retain copyright and release the work under
a Creative Commons Attribution 4.0 International License (CC BY
4.0)</license-p>
</license>
</permissions>
<kwd-group kwd-group-type="author">
<kwd>biostatistics</kwd>
<kwd>epidemiology</kwd>
<kwd>etiologic heterogeneity</kwd>
<kwd>clustering</kwd>
<kwd>disease subtypes</kwd>
<kwd>multinomial logistic regression</kwd>
<kwd>polytomous logistic regression</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="summary">
  <title>Summary</title>
  <p>Etiologic heterogeneity refers to the concept of subtypes of
  disease that are influenced by different risk factors. In cancer
  epidemiology, it is well known that many types of cancer demonstrate
  etiologic heterogeneity with respect to subtypes formed by genetic
  markers and/or other tumor characteristics. Likely the best known
  example of this is in breast cancer research, where subtypes are often
  formed based on immunohistochemical staining of estrogen receptor
  (ER), progesterone receptor (PR) and human epidermal growth factor
  receptor 2 (HER2). Risk factors, including patient characteristics
  such as age and body mass index as well as hormonal risk factors such
  as age at menarche, parity, and menopausal status, have been shown to
  have different relative risks for these disease subtypes
  (<xref alt="Gaudet et al., 2011" rid="ref-gaudet2011" ref-type="bibr">Gaudet
  et al., 2011</xref>;
  <xref alt="Kwan et al., 2009" rid="ref-kwan2009" ref-type="bibr">Kwan
  et al., 2009</xref>;
  <xref alt="Ma et al., 2010" rid="ref-ma2010" ref-type="bibr">Ma et
  al., 2010</xref>;
  <xref alt="Phipps et al., 2008" rid="ref-phipps2008" ref-type="bibr">Phipps
  et al., 2008</xref>;
  <xref alt="Yang et al., 2007" rid="ref-yang2007" ref-type="bibr">Yang
  et al., 2007</xref>). With the growing use of genetic testing, the
  search for disease subtypes will only become more common in cancer
  research, and across other disease areas. There may be three main
  goals in any study of etiologic heterogeneity: 1) quantifying the
  extent of etiologic heterogeneity for a given set of disease subtypes
  according to all known risk factors, 2) testing the etiologic
  heterogeneity of individual risk factors with respect to a given set
  of disease subtypes, and 3) identifying the most etiologically
  heterogeneous subtype solution from possibly high-dimensional disease
  marker data. The R
  (<xref alt="R Core Team, 2018" rid="ref-rct2018" ref-type="bibr">R
  Core Team, 2018</xref>) package <monospace>riskclustr</monospace>
  (<xref alt="Emily C. Zabor, 2019" rid="ref-zabor2019" ref-type="bibr">Emily
  C. Zabor, 2019</xref>) provides user-friendly functions to address all
  three areas of study.</p>
  <p>In previous work we introduced a scalar measure that can be used to
  quantify the extent of etiologic heterogeneity of pre-defined disease
  subtypes based on known risk factors in the context of a case-control
  study
  (<xref alt="Begg et al., 2013" rid="ref-begg2013" ref-type="bibr">Begg
  et al., 2013</xref>). Later work generalized this methodology to the
  context of case-only studies, as researchers are often working in
  hospital settings without access to control subjects
  (<xref alt="Begg et al., 2014" rid="ref-begg2014" ref-type="bibr">Begg
  et al., 2014</xref>). The R package <monospace>riskclustr</monospace>
  introduces original functionality to implement these methods to
  estimate the extent of etiologic heterogeneity in case-control studies
  using the <monospace>d</monospace> function and in case-only studies
  using the <monospace>dstar</monospace> function.</p>
  <p>Separately, we compared available statistical methods for the study
  of etiologic heterogeneity in case-control studies
  (<xref alt="E. C. Zabor &amp; Begg, 2017" rid="ref-zabor2017" ref-type="bibr">E.
  C. Zabor &amp; Begg, 2017</xref>). By unifying the notation of the
  different methods and employing simulations, we showed that the
  methods are all able to address two key research questions: 1) whether
  risk factor effects differ across subtypes of disease and 2) whether
  risk factor effects differ across levels of each individual disease
  marker of which the disease subtypes are comprised. Our research also
  showed that adaptation of polytomous logistic regression has
  statistical properties at least as good as the more sophisticated
  methods that have been proposed, provided that the number of disease
  markers is sufficiently small that the analysis is feasible
  (<xref alt="E. C. Zabor &amp; Begg, 2017" rid="ref-zabor2017" ref-type="bibr">E.
  C. Zabor &amp; Begg, 2017</xref>). In R polytomous logistic regression
  can be implemented using the <monospace>multinom</monospace> function
  from the <monospace>nnet</monospace> package
  (<xref alt="Venables &amp; Ripley, 2002" rid="ref-venables2002" ref-type="bibr">Venables
  &amp; Ripley, 2002</xref>) or the <monospace>mlogit</monospace>
  function from the <monospace>mlogit</monospace> package
  (<xref alt="Croissant, 2018" rid="ref-croissant2018" ref-type="bibr">Croissant,
  2018</xref>), but the additional calculations needed to perform an
  analysis of etiologic heterogeneity are cumbersome. To facilitate use
  of this method the R package <monospace>riskclustr</monospace>
  introduces functions <monospace>eh_test_subtype</monospace> and
  <monospace>eh_test_marker</monospace> that first fit a standard
  polytomous logistic regression model using the
  <monospace>mlogit</monospace> function from the
  <monospace>mlogit</monospace> package
  (<xref alt="Croissant, 2018" rid="ref-croissant2018" ref-type="bibr">Croissant,
  2018</xref>) and then perform additional calculations to address the
  two preceding questions regarding etiologic heterogeneity.</p>
  <p>Finally, it is increasingly common for statistical or epidemiologic
  researchers to be confronted with high dimensional disease marker data
  and when disease subtypes are not pre-defined, this disease marker
  data can be clustered, and the optimally etiologically heterogeneous
  subtype solution can be identified. This methodology has been applied
  to breast cancer
  (<xref alt="Begg et al., 2013" rid="ref-begg2013" ref-type="bibr">Begg
  et al., 2013</xref>,
  <xref alt="2015" rid="ref-begg2015" ref-type="bibr">2015</xref>) and
  melanoma
  (<xref alt="Mauguen et al., 2017" rid="ref-mauguen2017" ref-type="bibr">Mauguen
  et al., 2017</xref>) and the statistical properties of the approach
  have been investigated using simulation studies (Zabor et al, under
  review). In R
  (<xref alt="R Core Team, 2018" rid="ref-rct2018" ref-type="bibr">R
  Core Team, 2018</xref>) unsupervised <inline-formula><alternatives>
  <tex-math><![CDATA[k]]></tex-math>
  <mml:math display="inline" xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mi>k</mml:mi></mml:math></alternatives></inline-formula>-means
  clustering can be implemented using the <monospace>kmeans</monospace>
  function in the <monospace>stats</monospace> package
  (<xref alt="R Core Team, 2018" rid="ref-rct2018" ref-type="bibr">R
  Core Team, 2018</xref>), and the R package
  <monospace>riskclustr</monospace> includes a wrapper for the
  <monospace>kmeans</monospace> function that calculates the extent of
  etiologic heterogeneity using the <monospace>d</monospace> function
  for each cluster solution resulting from many random starts of the
  clustering algorithm, and returns the subtype solution that maximizes
  etiologic heterogeneity.</p>
  <p>The R package <monospace>riskclustr</monospace> was designed for
  use by researchers in epidemiology and biostatistics, and the
  open-source software package includes user-friendly tutorials that
  include examples of how to use the various functions and cover details
  of all underlying statistical calculations.</p>
</sec>
<sec id="acknowledgements">
  <title>Acknowledgements</title>
  <p>The research was supported by the National Cancer Institute, awards
  CA163251 and CA167237. Additional funding support was provided by the
  Core Grant (P30 CA008748).</p>
</sec>
</body>
<back>
<ref-list>
  <ref-list>
    <ref id="ref-begg2015">
      <element-citation publication-type="article-journal">
        <person-group person-group-type="author">
          <name><surname>Begg</surname><given-names>C. B.</given-names></name>
          <name><surname>Orlow</surname><given-names>I.</given-names></name>
          <name><surname>Zabor</surname><given-names>E. C.</given-names></name>
          <name><surname>Arora</surname><given-names>A.</given-names></name>
          <name><surname>Sharma</surname><given-names>A.</given-names></name>
          <name><surname>Seshan</surname><given-names>V. E.</given-names></name>
          <name><surname>Bernstein</surname><given-names>J. L.</given-names></name>
        </person-group>
        <article-title>Identifying etiologically distinct sub-types of cancer: A demonstration project involving breast cancer</article-title>
        <source>Cancer Med</source>
        <year iso-8601-date="2015">2015</year>
        <volume>4</volume>
        <issue>9</issue>
        <issn>2045-7634</issn>
        <pub-id pub-id-type="doi">10.1002/cam4.456</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-begg2014">
      <element-citation publication-type="article-journal">
        <person-group person-group-type="author">
          <name><surname>Begg</surname><given-names>C. B.</given-names></name>
          <name><surname>Seshan</surname><given-names>V. E.</given-names></name>
          <name><surname>Zabor</surname><given-names>E. C.</given-names></name>
          <name><surname>Furberg</surname><given-names>H.</given-names></name>
          <name><surname>Arora</surname><given-names>A.</given-names></name>
          <name><surname>Shen</surname><given-names>R.</given-names></name>
          <name><surname>Maranchie</surname><given-names>J. K.</given-names></name>
          <name><surname>Nielsen</surname><given-names>M. E.</given-names></name>
          <name><surname>Rathmell</surname><given-names>W. K.</given-names></name>
          <name><surname>Signoretti</surname><given-names>S.</given-names></name>
          <name><surname>Tamboli</surname><given-names>P.</given-names></name>
          <name><surname>Karam</surname><given-names>J. A.</given-names></name>
          <name><surname>Choueiri</surname><given-names>T. K.</given-names></name>
          <name><surname>Hakimi</surname><given-names>A. A.</given-names></name>
          <name><surname>Hsieh</surname><given-names>J. J.</given-names></name>
        </person-group>
        <article-title>Genomic investigation of etiologic heterogeneity: Methodologic challenges</article-title>
        <source>BMC Med Res Methodol</source>
        <year iso-8601-date="2014">2014</year>
        <volume>14</volume>
        <issn>1471-2288</issn>
        <pub-id pub-id-type="doi">10.1186/1471-2288-14-138</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-begg2013">
      <element-citation publication-type="article-journal">
        <person-group person-group-type="author">
          <name><surname>Begg</surname><given-names>C. B.</given-names></name>
          <name><surname>Zabor</surname><given-names>E. C.</given-names></name>
          <name><surname>Bernstein</surname><given-names>J. L.</given-names></name>
          <name><surname>Bernstein</surname><given-names>L.</given-names></name>
          <name><surname>Press</surname><given-names>M. F.</given-names></name>
          <name><surname>Seshan</surname><given-names>V. E.</given-names></name>
        </person-group>
        <article-title>A conceptual and methodological framework for investigating etiologic heterogeneity</article-title>
        <source>Stat Med</source>
        <year iso-8601-date="2013">2013</year>
        <volume>32</volume>
        <issue>29</issue>
        <issn>0277-6715</issn>
        <pub-id pub-id-type="doi">10.1002/sim.5902</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-gaudet2011">
      <element-citation publication-type="article-journal">
        <person-group person-group-type="author">
          <name><surname>Gaudet</surname><given-names>M. M.</given-names></name>
          <name><surname>Press</surname><given-names>M. F.</given-names></name>
          <name><surname>Haile</surname><given-names>R. W.</given-names></name>
          <name><surname>Lynch</surname><given-names>C. F.</given-names></name>
          <name><surname>Glaser</surname><given-names>S. L.</given-names></name>
          <name><surname>Schildkraut</surname><given-names>J.</given-names></name>
          <name><surname>Gammon</surname><given-names>M. D.</given-names></name>
          <name><surname>Douglas Thompson</surname><given-names>W.</given-names></name>
          <name><surname>Bernstein</surname><given-names>J. L.</given-names></name>
        </person-group>
        <article-title>Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger</article-title>
        <source>Breast Cancer Res Treat</source>
        <year iso-8601-date="2011">2011</year>
        <volume>130</volume>
        <issue>2</issue>
        <issn>0167-6806</issn>
        <pub-id pub-id-type="doi">10.1007/s10549-011-1616-x</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-kwan2009">
      <element-citation publication-type="article-journal">
        <person-group person-group-type="author">
          <name><surname>Kwan</surname><given-names>M. L.</given-names></name>
          <name><surname>Kushi</surname><given-names>L. H.</given-names></name>
          <name><surname>Weltzien</surname><given-names>E.</given-names></name>
          <name><surname>Maring</surname><given-names>B.</given-names></name>
          <name><surname>Kutner</surname><given-names>S. E.</given-names></name>
          <name><surname>Fulton</surname><given-names>R. S.</given-names></name>
          <name><surname>Lee</surname><given-names>M. M.</given-names></name>
          <name><surname>Ambrosone</surname><given-names>C. B.</given-names></name>
          <name><surname>Caan</surname><given-names>B. J.</given-names></name>
        </person-group>
        <article-title>Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors</article-title>
        <source>Breast Cancer Res</source>
        <year iso-8601-date="2009">2009</year>
        <volume>11</volume>
        <issue>3</issue>
        <issn>1465-5411</issn>
        <pub-id pub-id-type="doi">10.1186/bcr2261</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-ma2010">
      <element-citation publication-type="article-journal">
        <person-group person-group-type="author">
          <name><surname>Ma</surname><given-names>H.</given-names></name>
          <name><surname>Wang</surname><given-names>Y.</given-names></name>
          <name><surname>Sullivan-Halley</surname><given-names>J.</given-names></name>
          <name><surname>Weiss</surname><given-names>L.</given-names></name>
          <name><surname>Marchbanks</surname><given-names>P. A.</given-names></name>
          <name><surname>Spirtas</surname><given-names>R.</given-names></name>
          <name><surname>Ursin</surname><given-names>G.</given-names></name>
          <name><surname>Burkman</surname><given-names>R. T.</given-names></name>
          <name><surname>Simon</surname><given-names>M. S.</given-names></name>
          <name><surname>Malone</surname><given-names>K. E.</given-names></name>
          <name><surname>Strom</surname><given-names>B. L.</given-names></name>
          <name><surname>McDonald</surname><given-names>J. A.</given-names></name>
          <name><surname>Press</surname><given-names>M. F.</given-names></name>
          <name><surname>Bernstein</surname><given-names>L.</given-names></name>
        </person-group>
        <article-title>Use of four biomarkers to evaluate the risk of breast cancer subtypes in the womenâ€™s contraceptive and reproductive experiences study</article-title>
        <source>Cancer Res</source>
        <year iso-8601-date="2010">2010</year>
        <volume>70</volume>
        <issue>2</issue>
        <issn>0008-5472</issn>
        <pub-id pub-id-type="doi">10.1158/0008-5472.can-09-3460</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-mauguen2017">
      <element-citation publication-type="article-journal">
        <person-group person-group-type="author">
          <name><surname>Mauguen</surname><given-names>A.</given-names></name>
          <name><surname>Zabor</surname><given-names>E. C.</given-names></name>
          <name><surname>Thomas</surname><given-names>N. E.</given-names></name>
          <name><surname>Berwick</surname><given-names>M.</given-names></name>
          <name><surname>Seshan</surname><given-names>V. E.</given-names></name>
          <name><surname>Begg</surname><given-names>C. B.</given-names></name>
        </person-group>
        <article-title>Defining cancer subtypes with distinctive etiologic profiles: An application to the epidemiology of melanoma</article-title>
        <source>J Am Stat Assoc</source>
        <year iso-8601-date="2017">2017</year>
        <volume>112</volume>
        <issue>517</issue>
        <issn>0162-1459 (Print)
        0162-1459</issn>
        <pub-id pub-id-type="doi">10.1080/01621459.2016.1191499</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-phipps2008">
      <element-citation publication-type="article-journal">
        <person-group person-group-type="author">
          <name><surname>Phipps</surname><given-names>A. I.</given-names></name>
          <name><surname>Malone</surname><given-names>K. E.</given-names></name>
          <name><surname>Porter</surname><given-names>P. L.</given-names></name>
          <name><surname>Daling</surname><given-names>J. R.</given-names></name>
          <name><surname>Li</surname><given-names>C. I.</given-names></name>
        </person-group>
        <article-title>Body size and risk of luminal, HER2-overexpressing, and triple-negative breast cancer in postmenopausal women</article-title>
        <source>Cancer Epidemiol Biomarkers Prev</source>
        <year iso-8601-date="2008">2008</year>
        <volume>17</volume>
        <issue>8</issue>
        <issn>1055-9965 (Print)
        1055-9965</issn>
        <pub-id pub-id-type="doi">10.1158/1055-9965.epi-08-0206</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-yang2007">
      <element-citation publication-type="article-journal">
        <person-group person-group-type="author">
          <name><surname>Yang</surname><given-names>X. R.</given-names></name>
          <name><surname>Pfeiffer</surname><given-names>R. M.</given-names></name>
          <name><surname>Garcia-Closas</surname><given-names>M.</given-names></name>
          <name><surname>Rimm</surname><given-names>D. L.</given-names></name>
          <name><surname>Lissowska</surname><given-names>J.</given-names></name>
          <name><surname>Brinton</surname><given-names>L. A.</given-names></name>
          <name><surname>Peplonska</surname><given-names>B.</given-names></name>
          <name><surname>Hewitt</surname><given-names>S. M.</given-names></name>
          <name><surname>Cartun</surname><given-names>R. W.</given-names></name>
          <name><surname>Mandich</surname><given-names>D.</given-names></name>
          <name><surname>Sasano</surname><given-names>H.</given-names></name>
          <name><surname>Evans</surname><given-names>D. B.</given-names></name>
          <name><surname>Sutter</surname><given-names>T. R.</given-names></name>
          <name><surname>Sherman</surname><given-names>M. E.</given-names></name>
        </person-group>
        <article-title>Hormonal markers in breast cancer: Coexpression, relationship with pathologic characteristics, and risk factor associations in a population-based study</article-title>
        <source>Cancer Res</source>
        <year iso-8601-date="2007">2007</year>
        <volume>67</volume>
        <issue>21</issue>
        <issn>0008-5472</issn>
        <pub-id pub-id-type="doi">10.1158/0008-5472.can-07-2142</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-zabor2017">
      <element-citation publication-type="article-journal">
        <person-group person-group-type="author">
          <name><surname>Zabor</surname><given-names>E. C.</given-names></name>
          <name><surname>Begg</surname><given-names>C. B.</given-names></name>
        </person-group>
        <article-title>A comparison of statistical methods for the study of etiologic heterogeneity</article-title>
        <source>Stat Med</source>
        <year iso-8601-date="2017">2017</year>
        <volume>36</volume>
        <issue>25</issue>
        <issn>0277-6715</issn>
        <pub-id pub-id-type="doi">10.1002/sim.7405</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-rct2018">
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <string-name>R Core Team</string-name>
        </person-group>
        <source>R: A language and environment for statistical computing</source>
        <publisher-name>R Foundation for Statistical Computing</publisher-name>
        <publisher-loc>Vienna, Austria</publisher-loc>
        <year iso-8601-date="2018">2018</year>
        <uri>https://www.R-project.org/</uri>
      </element-citation>
    </ref>
    <ref id="ref-venables2002">
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name><surname>Venables</surname><given-names>W. N.</given-names></name>
          <name><surname>Ripley</surname><given-names>B. D.</given-names></name>
        </person-group>
        <source>Modern applied statistics with </source>
        <publisher-name>Springer</publisher-name>
        <publisher-loc>New York</publisher-loc>
        <year iso-8601-date="2002">2002</year>
        <uri>http://www.stats.ox.ac.uk/pub/MASS4</uri>
      </element-citation>
    </ref>
    <ref id="ref-croissant2018">
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name><surname>Croissant</surname><given-names>Yves</given-names></name>
        </person-group>
        <source>: Multinomial logit models</source>
        <year iso-8601-date="2018">2018</year>
        <uri>https://CRAN.R-project.org/package=mlogit</uri>
      </element-citation>
    </ref>
    <ref id="ref-zabor2019">
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name><surname>Zabor</surname><given-names>Emily C.</given-names></name>
        </person-group>
        <source>Riskclustr: Functions to study etiologic heterogeneity</source>
        <publisher-loc>https://github.com/zabore/riskclustr</publisher-loc>
        <year iso-8601-date="2019">2019</year>
      </element-citation>
    </ref>
  </ref-list>
</ref-list>
</back>
</article>
